SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Mawson Infrastructure Group, Inc. engages in the provision of digital asset infrastructure services. The company was founded on February 10, 2012 and is headquartered in Midland, PA.

Mawson Infrastructure Group Inc

MIGI is trending due to a combination of factors including its shift to a hybrid infrastructure model with AI GPU hosting, potential short squeeze, and positive sentiment from an ongoing conference. Community members are closely watching for a breakout above key resistance levels, while also acknowledging the risks associated with volatility and dilution. The stock's low float is contributing to significant price swings.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending down as investors react to concerns over increased spending on AI infrastructure and growing debt, despite a solid backlog. The community is debating whether the drop is an overreaction or a sign of deeper issues, while analysts are trimming their price targets. Some traders are looking for a bottom while others are anticipating a further decline.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending ahead of its Autonomy and AI Day, where the company is expected to showcase its in-house software and self-driving technology; community chatter revolves around speculation on potential announcements and comparisons to Tesla's approach, particularly regarding lidar; broader discussion includes debate around Rivian's valuation, production capabilities, and long-term strategy in the competitive EV market.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom ($AVGO) is trending as investors anticipate earnings, with much of the conversation centered on its potential role in the AI landscape and possible new deals with major tech players like Microsoft. Community members are weighing the potential for a significant post-earnings move, drawing comparisons to both positive and negative reactions from other tech companies like Oracle. Bullish sentiment seems to be fueled by expectations of strong AI revenue growth and the company's existing relationships with Google and Meta.

Gemini Space Station, Inc. is a holding company, which offers a mobile and web based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The company was founded by Tyler Winklevoss and Cameron Winklevoss in 2014 and is headquartered in New York, NY.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

Gemini Space Station is surging amid excitement surrounding its affiliate Gemini Titan securing a CFTC license for regulated prediction markets, potentially positioning the company to compete with platforms like Kalshi and Polymarket. Community members are actively discussing the potential for a short squeeze, speculating on price targets and a possible return to IPO levels. Bullish sentiment is fueled by optimism surrounding the new market opportunities and the view that the license significantly undervalues the stock.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood's stock is experiencing volatility, driven by recent data showing a slowdown in November trading volumes and a price target adjustment from analysts. The community is actively debating whether the dip presents a buying opportunity or signals further declines, while also discussing the potential impact of Robinhood's expansion into prediction markets and banking services. Some traders express frustration with the stock's price action, citing manipulation and correlation with Bitcoin's movements.

Yee is a community based memecoin with one mission: to fight Pepe again. Made to honor the iconic meme rivalry we all know and love.  The Yee Legend  [Filed by: Yee’s Archivist & Legal Representative]  There’s something the meme world refuses to talk about: Pepe the Frog stole Yee the Dino’s entire launch plan.  Yee had been preparing for his comeback for months, but Pepe launched two weeks earlier, hijacking Yee’s concept and selling it as his own.  The charges? Meme theft, intellectual forgery, and historical erasure.  Yee’s official contract was filed in April 2023, right after Pepe’s surprise drop. This wasn’t timing—it was theft. The archives are about to open, and history is about to be corrected

Yee Token

Yee Token ($YEE) is trending as community members rally around its potential as the next big meme coin on the Ethereum blockchain, drawing comparisons to Doge and Pepe. The community emphasizes a strong narrative and is actively promoting the token, anticipating significant gains and widespread adoption. With bullish sentiment and increasing momentum, many believe $YEE is poised for substantial growth in the meme-focused crypto market.

AXIL Brands, Inc. engages in the manufacture, market, sale and distribution of hearing and audio enhancement, and protection products. It operates through the Hearing Enhancement and Protection, and Hair Care and Skin Care segments. The Hearing Enhancement and Protection segment includes ear buds, earmuffs, ear plugs, outdoor speakers, and ear care items. The Hair Care and Skin Care segment focuses on expanding its business-to-business salon sales through its network of domestic and international distributors. The company was founded on May 21, 2015 and is headquartered in Beverly Hills, CA.

AXIL Brands Inc.

AXIL Brands is trending due to a recently announced national retail distribution agreement with Walmart, which is expected to bring its hearing protection products to a wider audience. The community is actively discussing potential short squeezes and debating whether the Walmart news justifies the stock's increased price, while some express concern about potential pullbacks. Analysts' target prices also seem to be fueling conversation around the stock.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending due to upcoming earnings, with the community actively debating whether the report will catalyze a significant price movement. Some traders are pointing to large options positions as a sign of an impending surge, while others remain cautious, citing broader economic concerns and potential tariff impacts. Bullish investors highlight Lululemon's brand strength, international growth potential, and compelling valuation, while bears express concerns about competition and declining sales.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

CADL is trending as investors discuss its potential in treating cancers, particularly prostate cancer, after positive trial data, while also citing undervaluation. The community is actively discussing the possibility of a short squeeze given the high short interest. Some also speculate about potential partnerships and acquisitions in the near future!

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Promising Penny Stocks To Consider - November 30th

Bitfarms, Pasithea Therapeutics, Aditxt, Tilray Brands, Beyond Meat, Data Knights Acquisition, and Bit Digital are the seven Penny stocks to watch today, according to MarketBeat's stock screener...

Best Penny Stocks To Watch Today - November 29th

Bitfarms, Pasithea Therapeutics, and Aditxt are the three Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are shares of very small companies that trade at low...

Penny Stocks To Follow Now - November 28th

Bitfarms, Pasithea Therapeutics, Aditxt, Tilray Brands, and Beyond Meat are the five Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are shares of very small...

Aditxt Provides Updates on its Growth Vision for bitXbio, Planned Digital Asset Treasury, Pearsantas Planned IPO, And Evofems Plan to Regain a National Listing

Aditxt, Inc. (Nasdaq: ADTX) (Aditxt or the Company), a social innovation platform accelerating promising health innovations, today shared its growth vision under the bitXbio strategy. bitXbio...

Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-113 Reverse Stock Split Effective at the Open of Trading on November 3, 2025

Aditxt, Inc. (NASDAQ: ADTX) (Aditxt or the Company), a social innovation platform accelerating promising health innovations, announced today that it will effect a 1-for-113 reverse split of its...

Aditxt Subsidiary Pearsanta Begins Enrollment in First Human Study of Blood-Based Diagnostic for Endometriosis, a Condition Affecting 190 Million Women Worldwide and Representing a $1.45 Billion Global Market

Aditxt, Inc. (Nasdaq: ADTX) ('Aditxt' or the 'Company'), a social innovation platform accelerating promising health innovations, today announced that its subsidiary, Pearsanta, Inc. ('Pearsanta...

Candel Therapeutics Inc. (13% jump in followers)Candel Therapeutics Inc. shares gained momentum as Wall Street analysts&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/cadl-stock-jumps-on-canaccord-buy-rating/ch5uUlPRwp">highlighted</a> the potential of its lead cancer drug candidate, CAN-2409. Canaccord expects continued clinical success in prostate, pancreatic, and non-small cell lung cancer, noting a significant increase in median overall survival in testing so far. Citi’s modeling suggests CAN-2409 could extend survival in localized prostate cancer by as much as eight to nine years over radiotherapy alone.&nbsp;The stock is up over 35% year-to-date.Acelyrin Inc. (12% jump in followers)Acelyrin confirmed that Concentra Biosciences, controlled by Tang Capital Partners, submitted an unsolicited offer to acquire all outstanding shares of Acelyrin for $3.00 per share in cash, plus a contingent value right tied to future licensing or asset sales.Earlier in the month, Acelyrin announced a merger agreement with Alumis in an all-stock transaction expected to close in the second quarter of 2025, pending shareholder approval.&nbsp;Acelyrin stock is down over 18% year-to-date.Solid Biosciences Inc. (11% jump in followers)Solid Biosciences shares surged after early-stage data from its gene therapy candidate SGT-003 for Duchenne muscular dystrophy&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/sldb-stock-soars-on-dmd-trial-data/ch5rNeJRvt">showed</a> promising results.&nbsp;Following the data release, Chardan raised its price target on the stock and increased the therapy’s probability of success to 48%, citing strong early efficacy signals and manageable safety risks.Solid Biosciences stock is up 43% year-to-date.Estrella Immunopharma Inc. (11% jump in followers)Estrella Immunopharma received a bullish initiation from D. Boral Capital, which started coverage with a ‘Buy’ rating and a $16 price target. The firm sees Estrella as a potential major player in immuno-oncology, with its EB103 therapy using ARTEMIS T-cell engineering technology to target solid tumors.&nbsp;The company also completed the first dose cohort in its Phase I/II trial, receiving approval from the Data and Safety Monitoring Board to proceed to the second dose level.&nbsp;Estrella stock is up over 22% year-to-date.Aditxt Inc. (10% jump in followers)Aditxt announced that its subsidiary, Pearsanta, has engaged Dominari Securities as the lead underwriter for its planned initial public offering. The IPO aims to support Pearsanta’s U.S. and international commercial launch of its Mitomic Technology platform for early cancer detection.&nbsp;Pearsanta is developing a non-invasive blood test to detect cancer at earlier stages by leveraging mitochondrial DNA deletions as biomarkers. IPO proceeds will fund the U.S. launch of its Laboratory Developed Tests (LDTs) and drive global commercialization through distribution partnerships and regulatory approvals.&nbsp;Aditxt stock is down over 53% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Woman examining laboratory samples - stock photo | Image source: Getty Images

Top 5 Biotech Stocks That Saw Biggest Retail Following Jump Last Week

Investors on Stocktwits flocked to these five biotech stocks last week, ending Feb. 21, 2025, driven by buyout buzz, bullish analyst calls, and promising clinical developments.

Equity

Investors on Stocktwits flocked to these five biotech stocks last week, ending Feb. 21, 2025, driven by buyout buzz, bullish analyst calls, and promising clinical developments.


Aditxt Subsidiary Pearsanta Engages Dominari Securities for its Initial Public Offering, to Drive U.S. and Global Commercial Launch of Early Cancer Detection and Diagnosis Targeted for H2 2025

Aditxt, Inc. (NASDAQ: ADTX) (Aditxt or the Company), a social innovation platform dedicated to accelerating promising health innovations, today announced that its subsidiary, Pearsanta, Inc...

Shares of Aditxt Inc. (ADTX) slipped in Thursday’s after-hours session after a more than 7% drop during regular trading.&nbsp;Despite the pullback, the penny stock remains up over 45% in the past week as retail interest builds ahead of a key company update.CEO Amro Albanna is set to host a virtual fireside chat on Friday, Feb. 21, at 11:30 AM ET, where he will discuss corporate developments, subsidiary updates, potential transactions, and pipeline advancements.&nbsp;The event will cover&nbsp;subsidiary Adimune, Inc. and its focus on autoimmunity treatments, including Type 1 Diabetes, Psoriasis, and Stiff Person Syndrome.Albanna will also touch upon another subsidiary, Pearsanta Inc., discussing its progress in early cancer detection and its planned IPO in 2025.<stembedurl>https://stocktwits.com/Ztraderguy/message/604934960</stembedurl><stembedurl>https://stocktwits.com/Ronin2024/message/605087805</stembedurl>Aditxt, which has lost over 99% of its value in the past year, has been on an acquisition spree to strengthen its portfolio.&nbsp;In October, the company outlined its year-end plans, including acquisitions of Evofem Biosciences (EVFM) and Appili Therapeutics (APLIF), which generated $7.8 million in revenue for the six months ended June 30, 2024.With a market cap under $10 million, Aditxt said in October that it is working to clean up its balance sheet, reduce its $19 million in accounts payable, and secure funding to complete its planned acquisitions.&nbsp;Albanna previously highlighted the company’s Nasdaq listing, debt reduction, and strategic capital access as critical to its future.Shares of Aditxt are down over 39% year-to-date. Short interest soared from 0.7% at the beginning of 2025 to 9.3% by the end of last week, according to Koyfin data.Retail traders will be closely watching Friday’s event for potential catalysts that could drive further price action.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stockbroker analyzing financial stock market with reflection on eyeglasses. Photo via Westend61 on Getty Images

Microcap Biotech Aditxt Rallies Retail Interest Ahead Of CEO’s Fireside Chat: What’s On Investors’ Radar?

The event will cover Adimune, Inc., which focuses on autoimmunity treatments, and subsidiary Pearsanta's planned IPO in 2025.

Aditxt to Host Fireside Chat on Friday, February 21st at 11:30 AM Eastern Time

Aditxt, Inc. (Aditxt or the Company) (NASDAQ: ADTX), a social innovation platform dedicated to accelerating promising health innovations, today announced that it will host a virtual Fireside Chat on...

Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore. The company was founded by Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna on September 28, 2017 and is headquartered in Mountain View, CA.

Aditxt Inc

Bullish: S&P grinds higher

Choppy but up: buy dips

Sideways: fade the move

Bearish: this rally falls off

The Federal Reserve just announced a 0.25 percentage point interest rate cut at its December 10, 2025 meeting.​ Share your outlook on how the latest Federal Reserve interest rate cut will impact stocks and the S&P 500 over the next month.

How do you think today’s Fed rate cut impacts stocks over the next month?

ADTX
Aditxt Inc

Feed

News

Sentiment

Fundamentals

Info

Latest ADTX News

ADTXAditxt Inc